Haleon (HLN) Net Income - Minority (2021 - 2022)
Haleon's (HLN) quarterly Net Income - Minority came in at -$33.2 million in Q3 2022, down 124.2% on a QoQ basis from -$14.8 million in Q4 2021.
Haleon (HLN) Net Income - Minority (2021 - 2022) Analysis & Trends
Haleon (HLN) has 2 years of Net Income - Minority data on file, last reported at -$33.2 million in Q3 2022.
- Quarterly Net Income - Minority changed N/A year-over-year to -$33.2 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$33.2 million (changed N/A YoY) and the FY2021 annual result came in at -$15.1 million, changed N/A from the prior year.
- Net Income - Minority fell to -$33.2 million in Q3 2022, from -$14.8 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of -$14.8 million in Q4 2021 to a low of -$33.2 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 20, 2022 | -33.24 Mn |
| Dec 31, 2021 | -14.83 Mn |